Advanced search
Start date

Analysis of blood components use in ICU in Brazil: case report

Grant number: 20/10177-9
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): April 01, 2021
Effective date (End): March 31, 2022
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal researcher:Isabel Cristina Céspedes
Grantee:Fernanda Flores de Alencar Colares
Home Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil


Blood transfusions are among the most prescribed treatments by doctors, especially in anemic patients. Although transfusion therapy may be beneficial in many cases, studies indicate that it has been excessively used, putting patients at risk, since the use of blood products may be associated with various complications such as infections and immunological reactions. In this context, a more conservative approach in relation to transfusion practice has been recommended, with the adoption of more restrictive and individualized limits. In intensive care units (ICUs), this approach has promising potential, given that it is a context in which anemia and the use of blood components are frequent. Considering this scenario, the objective of this work is to conduct data collection in order to analyze the transfusion behavior in ICU patients in Brazil. For this, we will carry out retrospective data collection for the year 2019 at the Blood Center linked to the Universidade Federal de São Paulo (UNIFESP), responsible for serving five large hospitals in the metropolitan region of São Paulo (SP). The collection will be performed through two documents used by the blood center: (1) request for blood components transfusion and (2) control of blood components transfusion. Our hypothesis is that the transfusion practice excessively occurs in ICU patients, not aligned with the current trend of reducing the use of blood components. After statistical analysis of the data, we hope to assess the way blood components have been used in Brazil, contributing to the implementation of patient blood management programs in the country, in order to optimize care in ICUs and reduce costs related to excessive transfusion practice.